Analyst Update: Merck & Co, Quality Systems, Align Tech

Analysts adjusted their ratings and price targets on Merck & Co., Inc. (MRK), Quality Systems, Inc. (QSII), and Align Technology, Inc. (ALGN)

Jan 29, 2016 at 3:17 PM

Analysts are weighing in today on healthcare interests Merck & Co., Inc. (NYSE:MRK), Quality Systems, Inc. (NASDAQ:QSII), and Align Technology, Inc. (NASDAQ:ALGN). Here's a quick roundup of today's brokerage notes on MRK, QSII, and ALGN.

MRK is shrugging off a price-target cut to $60 from $66 from BMO, after the U.S. Food and Drug Administration (FDA) approved its newest treatment for hepatitis C -- much to the dismay of this biotech rival. (Meanwhile, this sector peer got its own FDA nod.) Merck & Co., Inc. has shed roughly 17% of its value year-over-year, but is trading 2.2% higher at $50.26 today. Heading into the company's earnings report -- due before the open next Wednesday -- analysts are evenly split on the stock, giving seven "strong buys" and seven "holds." But option traders may be eyeing a post-earnings move higher. MRK has a Schaeffer's put/call open interest ratio (SOIR) of 0.49 -- lower than 98% of all readings from the past year. In other words, among options expiring in the next three months, traders hold calls over puts at a rate rarely seen.

QSII plunged 20.5% to trade at $12.94 -- dangerously close to its 10-year low of $12.00, seen in August -- after reporting fiscal third-quarter revenue short of expectations. Quality Systems, Inc. received four price-target cuts -- three of which were to $15 -- while Jefferies actually raised its price target to $15 from $12. Analysts in general have been bearish on the security, however, with 12 out of 16 assigning it a rating of "hold" or worse.
After reporting stronger-than-expected earnings and offering upbeat full-year guidance, ALGN is 10.4% higher at $65.72, having touched a new record high of $69.36 earlier. No fewer than five brokerage firms raised their price targets on Align Technology, Inc. today, the most ambitious of which came from Stifel, at $82. Quite a few shorts may be hitting the bricks after today's rally. Short interest on ALGN represents nearly eight sessions' worth of pent-up buying demand, at the stock's average pace of trading -- ample fuel for a short squeeze.

For other stocks in analysts' crosshairs, read Analyst Upgrades: Microsoft Corporation, J C Penney Company Inc, and Flextronics International Ltd. and Analyst Downgrades: Amazon.com, Inc., Alibaba Group Holding Ltd, and Electronic Arts Inc.

Follow @Schaeffers

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?